Garc’a-Delaney C,
S‡nchez-GarcŽs Mç, Figueiredo R, S‡nchez-Torres A, Gay-Escoda C. Clinical
significance of interleukin-1 genotype in smoking patients as a predictor of peri-implantitis:
A case-control study. Med Oral Patol Oral Cir Bucal. 2015 Nov 1;20 (6):e737-43.
doi:10.4317/medoral.20655
http://dx.doi.org/doi:10.4317/medoral.20655
1.
Cosyn J, Christiaens V, Koningsveld V, Coucke PJ, De Coster P, De Paepe A, et
al. An Exploratory Case-Control Study on the Impact of IL-1 Gene
Polymorphisms on Early Implant Failure. Clin Implant Dent Relat Res. 2014 Jul
26. [Epub ahead of print]. |
|
|
|
2.
Liao J, Li C, Wang Y, Ten MH, Sun X, Tian A, et al. Meta-analysis of the
association between common interleukin-1 polymorphisms and dental implant
failure. Mol Biol Rep. 2014;41:2789-98. |
|
|
|
3.
Zitzmann NU, Berglundh T. Definition and prevalence of peri-implant disease.
J Clin Periodontol. 2008;35:286-91. |
|
|
|
4.
Lang NP, Berglundh T. Working Group 4 of the Seventh European Workshop on
Periodontology: periimplant diseases: where are we now? Consensus of the
Seventh European Workshop on Periodontology. J Clin Periodontol.
2011;38:178-81. |
|
|
|
5.
Heitz-Mayfield L. Peri-implant diseases: diagnosis and risk indicators. J
Clin Periodontol. 2008;35:292-304. |
|
|
|
6.
Kornman KS. Interleukin 1 genetics, inflammatory mechanisms, and nutrigenetic
opportunities to modulate diseases of aging. Am J Clin Nutr.
2006;83:475S-83S. |
|
|
|
7.
Graves DT, Cochran D. The contribution of interleukin-1 and tumor necrosis
factor to periodontal tissue destruction. J Periodontol. 2003;74:391-401. |
|
|
|
8.
Andreiotelli M, Koutayas SP, Madianos PN, Strub JR. Relationship between
interleukin-1 genotype and peri-implantitis: a literature review.
Quintessence Int. 2008;39:289-98. |
|
|
|
9.
Greenstein G, Hart TC. Clinical utility of a genetic susceptibility test for
severe periodontitis. A clinical evaluation. J Am Dent Assoc. 2002;133:452-9. |
|
|
|
10.
Nicklin MJ, Weith A, Duff GW. A physical map of the region encompassing the
human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor
antagonist genes. Genomics. 1994;19:382-4. |
|
|
|
11.
Jansson H, Hamberg K, De Bruyn H, Bratthall G. Clinical consequences of IL-1
genotype on early implant failures in patients under periodontal maintenance.
Clin Implant Dent Relat Res. 2005;7:51-9. |
|
|
|
12.
Koldsland OC, Scheie AA, Aass AM. Prevalence of peri-implantitis related to
severity of the disease with different degrees of bone loss. J Periodontol.
2010;81:231-8. |
|
|
|
13.
Mombelli A, van Oosten MA, Schurch E, Land NP. The microbiota associated with
successful or failing osseointegrated titanium implants. Oral Microbiol
Immunol. 1987;2:145-51. |
|
|
|
14.
von Elm E, Altman DG, Egger M, Pocock SJ, G¿tzsche PC, Vandenbroucke JP, et
al. The Strengthening the Reporting of Observational Studies in Epidemiology
(STROBE) statement: guidelines for reporting observational studies. Lancet.
2007;370:1453-7. |
|
|
|
15.
Hamdy A, Ebrahem M. The effect of interleukin-1 allele 2 genotype (IL-1a -889
and IL-1b +3954) on the individual«s susceptibility to peri-implantitis:
case-control study. J Oral Implantol. 2011;37:325-34. |
|
|
|
16.
Lindhe J, Meyle J. Peri-implant disease: consensus report of the sixth
european workshop on periodontology. J Clin Periodontol. 2008;35:282-5. |
|
|
|
17.
Quirynen M, De Soete M, Van Steenberghe D. Infectious risks for oral
implants: a review of the literature. Clin Oral Implants Res. 2002;13:1-19. |
|
|
|
18.
Huynh-Ba G, Lang NP, Tonetti MS, Salvi GE. The association of the composite
IL-1 genotype with periodontitis progression and/or treatment outcomes: a
systematic review. J Clin Periodontol. 2007;34:305-17. |
|
|
|
19.
Renvert S, Persson R. Periodontitis as a potential risk factor for
peri-implantitis. J Clin Periodontol. 2009;36:9-14. |
|
|
|
20.
Schou S, Holmstrup P, Worthington HV, Esposito M. Outcome of implant therapy
in patients with previous tooth loss due to periodontitis. Clin Oral Implants
Res. 2006;17:104-23. |
|
|
|
21.
Dereka X, Mardas N, Chin S, Petrie A, Donos N. A systematic review on the
association between genetic predisposition and dental implant biological
complications. Clin Oral Implants Res. 2012;23:775-88. |
|
|
|
22.
Huynh-Ba G, Lang NP, Tonetti MS, Zwahlen M, Salvi GE. Association of the
composite IL-1 genotype with peri-implantitis: a systematic review. Clin Oral
Implants Res. 2008;19:1154-62. |
|
|
|
23.
Lachmann S, Kimmerle-Muller E, Axmann D, Scheideler D, Weber H, Haas R.
Association between peri-implant crevicular fluid volume, concentrations of
crevicular inflammatory mediators, and composite IL-1A -889 and IL-1B +3954
genotype. A Cross-sectional study on implant recall patients with and without
clinical signs of peri-implantitis. Clin Oral Implants Res. 2007;18:212-23. |
|
|
|
24.
Heitz-Mayfield L, Huynh-Ba G. History of treated periodontitis and smoking as
risk for implant therapy. Int J Oral Maxillofac Implants. 2009;24:39-68. |
|
|
|
25.
Rodr’guez-Arteta OF, Figueiredo R, Valmaseda-Castellon E, Gay-Escoda C.
Postoperative complications in smoking patients treated with implants: a
retrospective study. J Oral Maxillofac Surg. 2011;69:2152-7. |
|
|
|
26.
Strietzel FP, Reichart PA, Kale A, Kulkarni M, Wegner B, Kuchler I. Smoking
interferes with the prognosis of dental implant treatment: a systematic
review and meta-analysis. J Clin Periodontol. 2007;34:523-44. |
|
|
|
27.
Rinke S, Ohl S, Ziebolz D, Lange K, Eickholz P. Prevalence of periimplant
disease in partially edentulous patients: a practice-based cross-sectional
study. Clin Oral Implants Res. 2011;22:826-33. |
|
|
|
28.
Feloutzis A, Lang NP, Tonetti MS, BŸrgin W, BrŠgger U, Buser D, et al. IL-1
gene polymorphism and smoking as risk factors for peri-implant bone loss in a
well-maintained population. Clin Oral Implants Res. 2003;14:10-7. |
|
|
|
29.
Gruica B, Wang HY, Lang N, Buser D. Impact of IL-1 genotype and smoking
status on the prognosis of osseointegrated implants. Clin Oral Implants Res.
2004;15:393-400. |
|
|